Nimmi  Kapoor, MD

Nimmi S. Kapoor, MD, FACS

(she/her)

Associate Professor, Department of Surgery/Surgical Oncology

Languages

English

Education

Fellowships

Breast and Endocrine Cancer Research, New York Presbyterian Hospital, NYC, 2010
Breast Surgical Oncology, John Wayne Cancer Institute-Cedars Sinai Medical Center, Los Angeles, CA, 2012

Degrees

MD, Weill Cornell Medical College, NYC, 2004
BS, University of California, Los Angeles, CA, 2000

Residencies

General Surgery, New York Presbyterian Hospital, NYC, 2011
Surgical Oncology, Memorial Sloan-Kettering Cancer Center, NYC, 2011

Contact Information

Scientific Interests

Dr. Kapoor's research interests include identifying novel approaches to cancer treatment to decrease morbidity and improve patient outcome. Specifically she is interested in neoadjuvant clinical trials that identify targeted treatments for patients with early stage breast cancer and the application of cryoablation to aid in the treatment of specific breast cancer tumor types. Her secondary goals include identifying strategies that enhance the surgical management of breast cancer treatment amongst her trainees.

Highlighted Publications

Kapoor NS, Sim MS, Lin J, Giuliano AE. Long-term Outcome of Patients Managed WithSentinel Lymph Node Biopsy Alone for Node-Negative Invasive Breast Cancer. ArchSurg. 2012;147:1047-52. https://jamanetwork.com/journals/jamasurgery/article-abstract/1216546

Kapoor NS, Eaton A, King TA, Stempel SM, Patil SM, Morris EA, Brogi E, Morrow M.Should breast density influence patient selection for breast conserving surgery? AnnSurg Oncol. 2013; 20:600-6. https://link.springer.com/article/10.1245/s10434-012-2604-z

Kapoor NS, Shamonki J, Sim MS, Chung CT, Giuliano AE. Impact of multifocality andlymph node metastasis on the prognosis and management of microinvasive breastcancer. Ann Surg Oncol. 2013; 20:2576-81.https://link.springer.com/article/10.1245/s10434-013-2924-7

Kapoor NS, Curcio LD, Blakemore C, Bremner A, McFarland R, West JG, Banks KC.Multi-gene panel testing detects equal rates of pathogenic BRCA1/2 mutations and hasa higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at riskfor hereditary breast cancer. Ann Surg Oncol. 2015; 22:3282-3288.https://link.springer.com/article/10.1245/s10434-015-4754-2

Kapoor NS. Common and less-common complications associated with breast implants.Ann Wom Health. 2017; 1: 1002. http://www.remedypublications.com/open-access/pcommon-and-less-common-complications-associated-with-breast-implantsp-2290.pdf